Viatris Inc

VTRS remains in a Stage 2 advancing trend with a confirmed Momentum Breakout reinforcing a medium-term bullish bias. However, price is extended above the rising EMAs and in extreme overbought territory. Execution is deferred for a pullback into the 9/20 EMA zone near prior resistance to test support.

• ↑Q1 2026 revenue of $3.5B, up 3% YoY, demonstrating stable growth
• ↑Greater China sales +18% YoY driven by cardiovascular portfolio
• ↓Gross margins under pressure from pricing headwinds and competition